cmAngio® vs FEops HEARTguide

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by FEops

AI Verdict

While both tools leverage AI in cardiology, cmAngio® focuses on early cardiovascular risk assessment by detecting Breast Arterial Calcifications on mammograms. In contrast, FEops HEARTguide is designed for pre-procedural planning of structural heart interventions, utilizing predictive simulations and digital twin technology based on CT scans. They address different stages and aspects of cardiovascular patient care.

Choose cmAngio® if…

Choose cmAngio® if your primary objective is to non-invasively assess cardiovascular risk in women by detecting Breast Arterial Calcifications (BAC) on routine mammograms. This AI-powered tool is ideal for integrating cardiovascular health insights into breast screening workflows, enabling early risk identification without additional radiation or procedures.

View cmAngio® →

Choose FEops HEARTguide if…

Choose FEops HEARTguide if you require advanced, patient-specific planning and optimization for structural heart procedures. This platform is best suited for cardiologists and cardiothoracic surgeons who need predictive simulations and digital twin technology to accurately determine device sizing and positioning pre-operatively, aiming to improve procedural success and patient outcomes.

View FEops HEARTguide →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® FEops HEARTguide
Pricing Paid, out-of-pocket Unknown
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud Based platform
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® FEops HEARTguide
Tool Name cmAngiou00ae FEops HEARTguide
Company CureMetrix FEops NV
Primary Function FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes.
Core Technology/Methodology AI-based detection of Breast Arterial Calcifications (BAC) Predictive simulation technology, AI-based anatomical measurements, Digital twin technology for patient-specific replicas
Target Medical Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Cardiothoracic Surgery
Key Capabilities Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard; Compatible with any DICOM-compliant viewer; Adjustable operating point to meet clinical goals. Cloud-based platform with anytime, anywhere access; DICOM interface for CT scan upload; Semi-automatic identification and measurement of anatomical landmarks; Evaluation of device sizing and positioning pre-operatively.

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and FEops HEARTguide.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. FEops HEARTguideu2122 is a cloud-based AI and digital twin platform designed for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes.
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. FEops HEARTguideu2122 utilizes a DICOM interface for CT scan upload.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology specialties. FEops HEARTguideu2122 is tailored for Cardiology and Cardiothoracic Surgery.
cmAngiou00ae uses AI for the detection and visualization of Breast Arterial Calcifications on a scorecard. FEops HEARTguideu2122 employs predictive simulation technology, AI-based anatomical measurements, and digital twin technology for patient-specific replicas and pre-operative evaluation.
cmAngiou00ae enables BAC identification and reporting without additional radiation or procedures, aiding early cardiovascular risk assessment. FEops HEARTguideu2122 aims to optimize device sizing and positioning pre-operatively, potentially leading to improved patient outcomes in structural heart procedures.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.